X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (11) 11
index medicus (11) 11
humans (10) 10
transplantation (9) 9
female (8) 8
male (8) 8
adult (7) 7
hematology, oncology and palliative medicine (7) 7
middle aged (7) 7
treatment outcome (7) 7
analysis (6) 6
stem cells (6) 6
transplantation conditioning - methods (6) 6
young adult (6) 6
adolescent (5) 5
aged (5) 5
article (5) 5
hematopoietic stem cells (5) 5
cancer (4) 4
hematopoietic stem cell transplantation - methods (4) 4
oncology (4) 4
survival analysis (4) 4
bone marrow (3) 3
clinical trials (3) 3
disease-free survival (3) 3
hematopoietic cell transplantation (3) 3
hematopoietic stem cell transplantation (3) 3
immunology (3) 3
immunosuppressive agents - therapeutic use (3) 3
survival (3) 3
therapy (3) 3
transplantation, autologous (3) 3
unrelated donors (3) 3
versus-host-disease (3) 3
abridged index medicus (2) 2
allografts (2) 2
antilymphocyte serum - therapeutic use (2) 2
blood (2) 2
bone-marrow-transplantation (2) 2
care and treatment (2) 2
child (2) 2
child, preschool (2) 2
children (2) 2
comparative analysis (2) 2
diagnosis (2) 2
graft vs host disease - epidemiology (2) 2
graft-versus-host reaction (2) 2
hematopoietic stem cells - cytology (2) 2
impact (2) 2
infant (2) 2
leukemia (2) 2
leukemia, myeloid, acute - therapy (2) 2
lymphomas (2) 2
mortality (2) 2
myelodysplastic syndromes - therapy (2) 2
patients (2) 2
peripheral blood stem cell transplantation - adverse effects (2) 2
peripheral blood stem cell transplantation - methods (2) 2
peripheral blood stem cell transplantation - mortality (2) 2
precursor cell lymphoblastic leukemia-lymphoma - therapy (2) 2
proportional hazards models (2) 2
quality (2) 2
retrospective studies (2) 2
transplantation, homologous (2) 2
transplants & implants (2) 2
usage (2) 2
1st remission (1) 1
acute leukemia (1) 1
acute lymphocytic leukemia (1) 1
adolescent and young adults (1) 1
adults (1) 1
age factors (1) 1
aged, 80 and over (1) 1
allogeneic (1) 1
allogeneic blood (1) 1
analysis of variance (1) 1
animal cells (1) 1
animals (1) 1
antigens (1) 1
antigens, cd34 - analysis (1) 1
antigens, cd34 - immunology (1) 1
antilymphocyte serum - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
autografts (1) 1
autologous hct (1) 1
bacteria (1) 1
bad prognosis (1) 1
beam regimen (1) 1
biological materials (1) 1
biological products (1) 1
biometry (1) 1
blood cell count (1) 1
blood platelets - cytology (1) 1
blood preservation (1) 1
body fluids (1) 1
bone marrow transplantation (1) 1
bone marrow transplantation - mortality (1) 1
bone marrow transplantation - statistics & numerical data (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 164 - 173
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 11, pp. 1819 - 1827
Journal Article
Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 25, pp. 6698 - 6701
Publication bias is the preferential publication of research with positive results, and is a threat to the validity of medical literature. Preliminary evidence... 
HEMATOLOGY | Congresses as Topic | Humans | Journal Impact Factor | Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation | Publication Bias - statistics & numerical data | Periodicals as Topic - standards
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 2, pp. 513 - 520
Purpose The optimal preparative regimen for non-Hodgkin's lymphoma patients undergoing autologous peripheral blood stem cell transplantation (PBSCT) is... 
Radiology | Hematology, Oncology and Palliative Medicine | total body irradiation | Non-Hodgkin's lymphoma | peripheral blood stem cell transplantation | interstitial pneumonitis | BEAM regimen | MALIGNANT-LYMPHOMA | CYCLOPHOSPHAMIDE | BONE-MARROW-TRANSPLANTATION | PREPARATIVE REGIMENS | CHEMOTHERAPY | ALLOGENEIC BLOOD | ETOPOSIDE | ONCOLOGY | HIGH-DOSE THERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | BAD PROGNOSIS | Peripheral Blood Stem Cell Transplantation - adverse effects | Radiation Pneumonitis - etiology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Manitoba | Follow-Up Studies | Peripheral Blood Stem Cell Transplantation - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Cyclophosphamide - therapeutic use | Transplantation Conditioning - mortality | Whole-Body Irradiation - adverse effects | Young Adult | Time Factors | Adult | Dose Fractionation | Female | Transplantation Conditioning - adverse effects | Retrospective Studies | Transplantation Conditioning - methods | Whole-Body Irradiation - mortality | Peripheral Blood Stem Cell Transplantation - mortality | Etoposide - administration & dosage | Survival Rate | Treatment Outcome | Cytarabine - administration & dosage | Disease-Free Survival | Whole-Body Irradiation - methods | Melphalan - administration & dosage | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Aged | Lymphoma, Non-Hodgkin - mortality | Carmustine - administration & dosage | Chemotherapy | Stem cells | Radiation | Transplantation | Non-Hodgkin's lymphomas | Comparative analysis | Hematopoietic stem cells | Cancer | Index Medicus | BODY FLUIDS | WHOLE-BODY IRRADIATION | NEOPLASMS | BIOLOGICAL MATERIALS | IMMUNE SYSTEM DISEASES | HODGKINS DISEASE | TOXICITY | ANIMAL CELLS | MEDICINE | LYMPHOMAS | IRRADIATION | RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS | TRANSPLANTS | DISEASES | THERAPY | PNEUMONITIS | STEM CELLS | SOMATIC CELLS | EXTERNAL IRRADIATION | MATERIALS | BLOOD
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 10, pp. 1815 - 1822
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1828 - 1838
BACKGROUND To evaluate the impact of depression before autologous and allogeneic hematopoietic cell transplantation (HCT) on clinical outcomes... 
autologous HCT | GVHD | depression | transplant outcomes | pre‐HCT depression | pre-HCT depression | LONG-TERM SURVIVORS | BONE-MARROW-TRANSPLANTATION | VERSUS-HOST-DISEASE | CHRONIC GRAFT | CANCER-PATIENTS | HOSPITAL LENGTH | RISK-FACTOR | ONCOLOGY | PREDICTORS | QUALITY-OF-LIFE | PSYCHOSOCIAL FACTORS | Multivariate Analysis | Graft vs Host Disease - epidemiology | Prognosis | Multiple Myeloma - psychology | Humans | Middle Aged | Male | Transplantation, Autologous | Transplantation, Homologous | Young Adult | Multiple Myeloma - therapy | Myelodysplastic Syndromes - therapy | Lymphoma - therapy | Aged, 80 and over | Adult | Female | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Leukemia - therapy | Treatment Outcome | Myelodysplastic Syndromes - psychology | Adolescent | Depression - psychology | Aged | Lymphoma - psychology | Depressive Disorder - psychology | Transplantation Conditioning | Leukemia - psychology | Treatment outcome | Usage | Analysis | Stem cells | Graft versus host reaction | Transplantation | Diagnosis | Graft-versus-host reaction | Autografts | Transplants & implants | Complications | Health risks | Stem cell transplantation | Risk | Regression analysis | Mental depression | Patients | Survival | Clinical outcomes | Hemopoiesis | Incidence | Confidence intervals | Quality | Cancer | Depression | Transplant Outcomes | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Hematologi | Cancer and Oncology | Cancer och onkologi
Journal Article
Trials, ISSN 1745-6215, 05/2019, Volume 20, Issue 1, p. 263
BackgroundMultiple sclerosis (MS) is an inflammatory disease of the central nervous system with a degenerative component, leading to irreversible disability.... 
Mesenchymal stromal cells | Clinical trial | Multiple sclerosis | Mesenchymal stem cells | MEDICINE, RESEARCH & EXPERIMENTAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | NEUROLOGICAL DISEASES | TRANSPLANTATION | Treatment outcome | Care and treatment | Usage | Analysis | Stem cells | Clinical trials | Research
Journal Article
Haematologica, ISSN 0390-6078, 11/2017, Volume 102, Issue 11, pp. 1936 - 1946
Randomized trials have conclusively shown higher rates of chronic graft- versus -host disease with filgrastim-stimulated apheresis peripheral blood as a donor... 
Journal Article
Transfusion, ISSN 0041-1132, 03/2011, Volume 51, Issue 3, pp. 587 - 590
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 10/2013, Volume 3, Issue 10, pp. e153 - e153
Fludarabine, a nucleoside analogue, is commonly used in combination with other agents for the treatment of chronic lymphocytic leukaemia (CLL). In previous... 
Cathepsin | CLL | VPA | Lysosome | HDAC | DIAGNOSIS | MGCD0103 | GUIDELINES | RECEPTOR | DEATH | PERMEABILIZATION | RELEASE | cathepsin | THERAPY | ONCOLOGY | HISTONE DEACETYLASE INHIBITORS | HEMATOLOGY | lysosome | CASPASE ACTIVATION | Original
Journal Article